Imagine if high volume and viscosity biologics could be self- injected with increased confidence and reduced patient anxiety.
Chronic disease management is undergoing a paradigm shift towards self-management. Needle-anxiety, frequent injections, and device complexity can lead to poor compliance and sub-optimal therapeutic benefit indicating an unmet need for innovative injection systems.
Benefits of our devices
Microneedles reduce needle-anxiety and pain perception
Near 100% of the dose is delivered to the intended depth
Emerging evidence indicates a potential therapeutic benefit to the intradermal delivery of biologics:
- Increased bioavailability (vs subcutaneous injection)
- Faster absorption
- Increased Cmax
- Enhanced efficacy due to efficient lymphatic trafficking
- Reduced systemic A/E’s
- Improved anti-tumour activity